Pillstats
Rx only · Suspension · Topical

Spinosad

Brands: Natroba · Spinosad

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)299081
US makers3 labelers
Packages5
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.603$1.21$1.81$2.41Dec 2025Mar 2026Jul 2026
$2.096
Latest avg · Jul 22, 2026
+5%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

29K58K87K116K2025 Q12025 Q22025 Q32025 Q42026 Q1
72K
Rx · 2026 Q1
8.8M
Units dispensed
-17%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
ParaPRO LLCunknown2SUPPLYING
Cipher Pharmaceuticals Inc.unknown2SUPPLYING
Allegis Pharmaceuticals, LLCunknown1EXITED 2027

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.